Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores.

NPJ Vaccines
Jamie Benn FelixWalter E Cook

Abstract

An oral vaccine against anthrax (Bacillus anthracis) is urgently needed to prevent annual anthrax outbreaks that are causing catastrophic losses in free-ranging livestock and wildlife worldwide. The Sterne vaccine, the current injectable livestock vaccine, is a suspension of live attenuated B. anthracis Sterne strain 34F2 spores (Sterne spores) in saponin. It is not effective when administered orally and individual subcutaneous injections are not a practical method of vaccination for wildlife. In this study, we report the development of a microencapsulated oral vaccine against anthrax. Evaluating Sterne spore stability at varying pH's in vitro revealed that spore exposure to pH 2 results in spore death, confirming that protection from the gastric environment is of main concern when producing an oral vaccine. Therefore, Sterne spores were encapsulated in alginate and coated with a protein shell containing poly-L-lysine (PLL) and vitelline protein B (VpB), a non-immunogenic, proteolysis resistant protein isolated from Fasciola hepatica. Capsule exposure to pH 2 demonstrated enhanced acid gel character suggesting that alginate microcapsules provided the necessary protection for spores to survive the gastric environment. Post vacci...Continue Reading

References

Sep 1, 1992·Molecular and Biochemical Parasitology·A C Rice-FichtJ H Waite
Sep 1, 1992·Molecular and Biochemical Parasitology·J H Waite, A C Rice-Ficht
Mar 1, 1986·Infection and Immunity·S L WelkosP H Gibbs
Jun 1, 1996·Biomaterials·B ThuG Skjåk-Braek
Sep 4, 1999·Journal of Applied Microbiology·F BrossierJ C Sirard
Apr 9, 2001·Infection and Immunity·S ReuvenyB Velan
Apr 27, 2002·Revue Scientifique Et Technique·M E Hugh-Jones, V de Vos
Apr 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sinjan De, Dennis Robinson
Jun 12, 2004·Advanced Drug Delivery Reviews·Th F Vandamme, K J Ellis
Nov 25, 2004·Advanced Drug Delivery Reviews·Tazio StorniPål Johansen
Feb 10, 2006·Clinical and Vaccine Immunology : CVI·James F HansonAlison A Weiss
Sep 12, 2006·Cellular and Molecular Life Sciences : CMLS·A ScorpioD J Chabot
Mar 7, 2007·Infection and Immunity·Subhendu BasuAlan S Cross
May 4, 2007·Cellular Microbiology·Brooke H RussellYi Xu
Jul 17, 2007·Clinical Microbiology Reviews·Els N T MeeusenGregers Jungersen
Jul 25, 2007·Journal of Biomedical Materials Research. Part a·Catherine K Kuo, Peter X Ma
Dec 11, 2007·Cellular Microbiology·Brooke H RussellYi Xu
Jan 11, 2008·BMC Biotechnology·Ricardo PintoMiguel Gama
Apr 1, 2008·International Journal of Medical Microbiology : IJMM·Michael J HudsonStefan H E Kaufmann
Feb 11, 2009·Journal of Wildlife Diseases·Angela M Arenas-GamboaAllison C Rice-Ficht
Sep 2, 2009·Molecular Aspects of Medicine·Martin Hugh-Jones, Jason Blackburn
Sep 15, 2009·Veterinary Microbiology·Antonio FasanellaMartin Hugh Jones
Jan 19, 2010·Current Opinion in Microbiology·Allison C Rice-FichtThomas A Ficht
Jun 16, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael T CookVitaliy V Khutoryanskiy
Nov 13, 2012·Biopharmaceutics & Drug Disposition·Shih-Fan JangJason T McConville
Feb 26, 2010·Science and Technology of Advanced Materials·Sushmitha SundarSubhas C Kundu
Apr 13, 2017·The Journal of Experimental Medicine·Min-Kyung ChooJin Mo Park
Apr 26, 2017·Advanced Drug Delivery Reviews·Julia E Vela RamirezNicholas A Peppas
May 20, 2017·Carbohydrate Polymers·Guillermo SimóJosé Manuel Rodríguez-Nogales

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

ImageJ

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.